Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Schattenberg, J.M.
~ 700  Ergebnisse:
Personensuche X
?
1

Risk of all-cause mortality and adverse outcomes from steat..:

Michel, Maurice ; Armandi, Angelo ; Gieswinkel, Alexander...
Journal of Clinical and Experimental Hepatology.  14 (2024)  - p. 102248 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Accuracy of a dedicated 100 Hz vibration-controlled spleen ..:

Armandi, A. ; Sanavia, T. ; Vanderschueren, E....
Digestive and Liver Disease.  56 (2024)  - p. S66-S67 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Noninvasive assessment of liver disease severity in patient..:

Pennisi, G. ; Enea, M. ; Falco, V....
Digestive and Liver Disease.  55 (2023)  - p. S12-S13 , 2023
Link: https://doi.org/10.1016/..
 
?
4

PCR34 Understanding the Experience of Patients with Primary..:

Levy, C. ; Williams, B. ; Sowell, F....
Value in Health.  26 (2023)  6 - p. S318 , 2023
Link: https://doi.org/10.1016/..
 
?
5

The use of Spleen Stiffness Measurement for the detection o..:

Armandi, A. ; Labenz, C. ; Werner, M.M....
Digestive and Liver Disease.  54 (2022)  - p. S19-S20 , 2022
Link: https://doi.org/10.1016/..
 
?
6

OC-07A machine learning approach for the classification of ..:

Sabatini, S. ; Gaggini, M. ; Allison, M....
Digestive and Liver Disease.  53 (2021)  - p. S4 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Applicability and safety of discontinuous ADVanced Organ Su..:

Kaps, L. ; Ahlbrand, C. J. ; Gadban, R....
PLOS ONE.  16 (2021)  4 - p. e0249342 , 2021
Link: https://doi.org/10.1371/..
 
?
8

PGI21 NO Association between the non-Alcoholic Fatty LIVER ..:

Labenz, C. ; Zingel, R. ; Kostev, K..
Value in Health.  23 (2020)  - p. S536 , 2020
Link: https://doi.org/10.1016/..
 
?
9

T06.01.12 OBETICHOLIC ACID (OCA) IMPROVES NON-INVASIVE MARK..:

Anstee, Q.M. ; Harrison, S. ; Sanyal, A.J....
Digestive and Liver Disease.  52 (2020)  - p. S163 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Obeticholic acid (OCA) improves non-invasive markers of fib..:

Anstee, Q.M. ; Harrison, S. ; Sanyal, Arun J....
Digestive and Liver Disease.  52 (2020)  - p. e41-e42 , 2020
Link: https://doi.org/10.1016/..
 
?
11

PGI27 THE BURDEN OF NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN..:

Le Pen, C. ; Fricke, F.U. ; Newsome, P....
Value in Health.  22 (2019)  - p. S621 , 2019
Link: https://doi.org/10.1016/..
 
?
12

PDB125 PREDICTING NASH PATIENTS USING INNOVATIVE MACHINE LE..:

Docherty, M. ; Huang, J. ; Regnier, S.A....
Value in Health.  22 (2019)  - p. S595 , 2019
Link: https://doi.org/10.1016/..
 
?
13

PGI44 - PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) ..:

Cook, N.S. ; Balp, M. ; Chatterjee, S....
Value in Health.  21 (2018)  - p. S148-S149 , 2018
Link: https://doi.org/10.1016/..
 
?
14

PGI43 - WHAT DO PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS..:

Cook, N.S. ; Balp, M. ; Chatterjee, S....
Value in Health.  21 (2018)  - p. S148 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Prospective evaluation of the impact of covert hepatic ence..:

Labenz, C. ; Baron, J. S. ; Toenges, G....
Alimentary Pharmacology & Therapeutics.  48 (2018)  3 - p. 313-321 , 2018
Link: https://doi.org/10.1111/..
 
1-15